You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Refractory SCLC

Showing 1 - 25 of 9,201
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Small-cell Lung Cancer, Neuroendocrine Carcinoma Trial (Iadademstat, Paclitaxel)

Not yet recruiting
  • Small-cell Lung Cancer
  • Neuroendocrine Carcinoma
  • (no location specified)
Jun 13, 2022

Small Cell Lung Cancer Trial in Worldwide (BMS-986012 (anti-fucosyl-GM1), Nivolumab)

Active, not recruiting
  • Small Cell Lung Cancer
  • BMS-986012 (anti-fucosyl-GM1)
  • Nivolumab
  • New York, New York
  • +15 more
Sep 28, 2022

Small Cell Lung Cancer (SCLC), Large Cell Neuroendocrine Cancer (LCNEC), Neuroendocrine Prostate Cancer (NEPC) Trial (PT217)

Not yet recruiting
  • Small Cell Lung Cancer (SCLC)
  • +3 more
  • (no location specified)
Dec 7, 2022

SCLC, Extensive Stage Trial in Tianjin (DLL3-CAR-NK cells)

Recruiting
  • SCLC, Extensive Stage
  • DLL3-CAR-NK cells
  • Tianjin, Tianjin, China
    Tianjin Medical University Cancer Institute and Hospital
Aug 18, 2022

Advanced Breast Cancer, Treatment-Refractory Solid Tumors, Retinoblastoma Deficiency Trial in Providence (Palbociclib Oral

Not yet recruiting
  • Advanced Breast Cancer
  • +6 more
  • Providence, Rhode Island
    Lifespan Cancer Institute
Feb 1, 2023

Relapsed Small Cell Lung Cancer, Refractory Small Cell Lung Carcinoma Trial (Venetoclax 50 MG, Venetoclax 100 MG, Venetoclax 200

Withdrawn
  • Relapsed Small Cell Lung Cancer
  • Refractory Small Cell Lung Carcinoma
  • Venetoclax 50 MG
  • +6 more
  • (no location specified)
Mar 1, 2021

Small Cell Lung Cancer Recurrent Trial in Goyang-si (Atezolizumab)

Recruiting
  • Small Cell Lung Cancer Recurrent
  • Goyang-si, Gyeonggi-do, Korea, Republic of
    National Cancer Center
Apr 4, 2022

Small Cell Lung Cancer Trial in Tampa, Houston (AMG 119)

Suspended
  • Small Cell Lung Cancer
  • AMG 119
  • Tampa, Florida
  • +1 more
Nov 29, 2021

Small Cell Lung Cancer (SCLC), Follicular Lymphoma (FL), Castration Resistant Prostate Cancer (CRPC) Trial in Russian

Recruiting
  • Small Cell Lung Cancer (SCLC)
  • +2 more
  • Tucson, Arizona
  • +62 more
Jan 18, 2023

SCLC, Malignant Melanoma, Sarcoma Trial (GD2-SADA:177Lu-DOTA Complex)

Not yet recruiting
  • SCLC
  • +2 more
  • GD2-SADA:177Lu-DOTA Complex
  • (no location specified)
May 4, 2022

Small-cell Lung Cancer, Small Cell Lung Carcinoma Trial in Augusta (Nivolumab 10 MG/ML Intravenous Solution [OPDIVO], Irinotecan

Recruiting
  • Small-cell Lung Cancer
  • Small Cell Lung Carcinoma
  • Nivolumab 10 MG/ML Intravenous Solution [OPDIVO]
  • Irinotecan Injection [Camptosar]
  • Augusta, Georgia
    Georgia Cancer Center at AU Medical Center
Jul 31, 2021

Small-cell Lung Cancer, Small Cell Lung Carcinoma, Small Cell Lung Cancer Extensive Stage Trial in Worldwide (KRT-232)

Recruiting
  • Small-cell Lung Cancer
  • +3 more
  • Fort Myers, Florida
  • +29 more
Jun 15, 2022

Metastatic Malignant Solid Tumor, Recurrent Lung Small Cell Carcinoma, Recurrent Malignant Solid Tumor Trial in United States

Terminated
  • Metastatic Malignant Solid Neoplasm
  • +8 more
  • Los Angeles, California
  • +13 more
Oct 7, 2022

Extensive-stage Small-cell Lung Cancer Trial in Pittsburgh (Durvalumab 50 MG/1 ML Intravenous Solution, Etoposide Injection,

Not yet recruiting
  • Extensive-stage Small-cell Lung Cancer
  • Durvalumab 50 MG/1 ML Intravenous Solution
  • +4 more
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Oct 31, 2022

SCLC, Small Cell Cancer, Advanced Solid Tumor Trial run by the NCI (Lurbinectedin, Berzosertib)

Recruiting
  • SCLC
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 20, 2023

Relapsed/Refractory Small Cell Lung Cancer Trial in Worldwide (Tarlatamab)

Recruiting
  • Relapsed/Refractory Small Cell Lung Cancer
  • Birmingham, Alabama
  • +78 more
Jan 18, 2023

Urothelial Carcinoma, Urothelial Cancer, Lung Tumors Trial run by the NCI (EP0057, olaparib)

Recruiting
  • Urothelial Carcinoma
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Small Cell Lung Carcinoma Trial in Worldwide (coformulation pembrolizumab/quavonlimab, lenvatinib, MK-4830)

Active, not recruiting
  • Small Cell Lung Carcinoma
  • coformulation pembrolizumab/quavonlimab
  • +3 more
  • Gilbert, Arizona
  • +46 more
Jan 2, 2023

Solid Tumor, TNBC - Triple-Negative Breast Cancer, Hormone Receptor-positive Breast Cancer Trial in United States (TH1902)

Recruiting
  • Solid Tumor
  • +8 more
  • Los Angeles, California
  • +5 more
Jun 27, 2022

Treatment Patterns in Advanced Small Cell Lung Cancer (SCLC)

Completed
  • Lung Cancer
    • Barcelona, Spain
    • +1 more
    Jan 11, 2022

    Extensive-stage Small-cell Lung Cancer Trial in Japan, United States (DS-7300a)

    Recruiting
    • Extensive-stage Small-cell Lung Cancer
    • Ifinatamab Deruxtecan (I-DXd)
    • Jacksonville, Florida
    • +22 more
    Jan 10, 2023

    Extranodal NK T Cell Lymphoma, NK-Cell Leukemia Trial in Xuzhou (Anti-CD56 CAR T)

    Recruiting
    • Extranodal NK T Cell Lymphoma
    • NK-Cell Leukemia
    • Anti-CD56 CAR T
    • Xuzhou, Jiangsu, China
      The Affiliated Hospital of Xuzhou Medical University
    Jul 10, 2023

    Small Cell Lung Cancer Trial in Worldwide (ADI-PEG 20 (Arginine deiminase pegylated))

    Terminated
    Has Results
    • Small Cell Lung Cancer
    • ADI-PEG 20 (Arginine deiminase pegylated)
    • New York, New York
    • +7 more
    Oct 3, 2022

    Stage IV NSCLC (NSCLC), Recurrent NSCLC (NSCLC), Extensive-stage Small Cell Lung Cancer (SCLC) Trial in Stanford (Pegylated

    Completed
    Has Results
    • Stage IV Non-small Cell Lung Cancer (NSCLC)
    • +5 more
    • Pegylated Irinotecan
    • Stanford, California
      Stanford University, School of Medicine
    Nov 4, 2019

    Solid Tumors and Hematologic Malignancy Trial in Belgium, Netherlands, United States (INCB059872, all-trans retinoic acid

    Terminated
    • Solid Tumors and Hematologic Malignancy
    • Birmingham, Alabama
    • +14 more
    Jun 29, 2022